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Pertussis toxin (PT), which blocks the activity of several G-proteins, has been found to exert a marked inhibitory effect 
on the DNA synthesis induced in 3T3 cells by serum or growth factors. 3T3 cells transformed with human c-rus oncogenes 
(Ha-ras, Ki-ras, N-W) or with src, an oncogene coding for a protein kinase, have lost sensitivity to growth control by 
PT, even though substrates for PT can still be ADP-ribosylated in vivo. In contrast, 3T3 cells transformed with the SV40 
virus behave like normal untransformed cells with respect o the ability of PT to decrease their growth rate. Oncogenes 
can thus likely be classified either as ‘responders’ or ‘non-responders’ to PT. 
Pertussis toxin; Oncogene; Polyphosphoinositide breakdown; (3T3 fibroblast) 
1. INTRODUCTION 
Activated ras oncogenes appear to play a major 
role in several human cancers. In this gene family, 
Ha-ras, K-ras and N-ras, which have been well 
characterized [11, code for a 21 kDa guanosine tri- 
phosphate-binding protein (~21) which is related to 
signal transducing G-proteins [2] and is believed to 
play a role in growth-signal transduction. The 
similarities between the ras and G-proteins are 
based on their GTP-binding consensus region and 
their co-localization on the inner surface of the 
plasma membrane. GTP-binding proteins such as 
Gi and G, regulate the adenylate cyclase system [2]. 
In the case of mast cells, neutrophils and hamster 
fibroblasts, receptor-mediated breakdown of phos- 
phatidylinositol 4,5-bisphosphate (PIP2) is abo- 
lished by pertussis toxin (PT) ADP-ribosylation of 
another G-protein called G, [3,4]. It has been sug- 
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gested that the mammalian ras family proteins 
could act as regulatory components of inositol pro- 
duction [5,6]. However, more recent work showed 
apparently contradictory results [7,8]. Thus, the 
question as to whether the ras proteins would func- 
tion as authentic coupling G-proteins is still open. 
It has been observed [9,10] that PT, which blocks 
the activity of several G-proteins, exerts a dramatic 
inhibitory effect on the DNA synthesis induced in 
3T3 cells by serum and growth factors (GFs). Here, 
we study the response of oncogene(s) transformed 
3T3 cells to PT treatment. The data show that, 
after PT treatment, mitogenic signals controlled by 
G-proteins can no longer influence Ha-ras and WC- 
transformed 3T3 cell growth, but are still active in 
SV40 virus-transformed cells. Our results also sug- 
gest that mutated ras proteins might control trans- 
duction of GFs which stimulate PIP2 breakdown at 
a step subsequent to the polyphosphoinositide 
phosphodiesterase (phospholipase C). 
2. MATERIALS AND METHODS 
2.1. Cell lines 
ESC-3T3 fibroblasts [ll], 3T3/src and 3T3/SV40 were 
cultured in modified Eagle’s medium (MEM) enriched with 10% 
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newborn calf serum. 3T3/Ha-ras cells were cultured in the same 
medium supplemented with glucose (3.2 g/l) and tryptose phos- 
phate broth (2.7 g/l). The 3T3/Ha-ras cells are ESC cells trans- 
formed with the high molecular mass (HMM) DNA from a 
stomach human tumor bearing an activated Ha-ras gene [l I]. 
HMM DNA was extracted and purified according to [12]. 
Transfections were carried out as in [l l] using the calcium phos- 
phate precipitation method. 3T3 cells transformed with the c-src 
gene were a gift from Dr Cl. Goubin (Institut Curie, Paris). 
3T3/SV40 cells were transformed in our laboratory by infection 
of 3T3 ESC cells with the complete SV40 virus (stock LP). 
2.2. Stimulation of cell growth by newborn calf serum in a PT- 
dependent manner 
Cell growth rates were determined by plating the different cell 
lines in 24-well (diameter: 15 mm) plates. PT kept in saturated 
ammonium sulfate was diluted to the required concentration in 
phosphate buffer. Control cells received the same dilution of 
ammonium sulfate. The medium was changed every 2 days and 
fresh toxin was added. Cells were counted from triplicate plates 
with a haemocytometer after trypsinization with 6.5 ml of 
0.25% trypsin in phosphate buffer. 
2.3. Soft agar assay 
The soft agar assay was carried out as described [13]. Briefly, 
cell suspensions in culture medium containing 0.33O70 agar were 
seeded in 60 mm Petri dishes and allowed to solidify for 5 min 
at 4°C to prevent cell sedimentation. Pretreatment with PT tox- 
in (100 ng/ml) was carried out for 20 h at 37°C. The number of 
colonies growing in agar was determined after 18 days of in- 
cubation at 37°C under 50/o carbon dioxide. Colonies larger 
than 50 pm in size were counted from quadruplicate plates. 
2.4. ADP-ribosylation assay 
PT (1 mg/ml) kept at 4°C in saturated ammonium sulfate 
was prepared for use by IO-fold dilution with 100 mM 
potassium phosphate (pH 8.0) and dialysis for two 30-min 
periods against 100 mM potassium phosphate (pH 8.0). The 
toxin was then activated with an equal volume of 100 mM DTT 
and stored for 1 h at room temperature. Cells were treated in the 
presence or absence of PT (100 ng/ml) overnight at 37°C. 
1OOlg homogenates prepared from each cell line were 
assayed for pertussis toxin substrates in a total volume of 50 pl 
containing 250 mM potassium phosphate (pH 7.0), 3 PM [“PI- 
NAD (10’ cpm), 20 mM thymidine, 1 mM ATP, 0.1 mM GTP, 
20 mM arginine HCI, 5 mM DTT and 6 pg activated PT. In- 
cubations were carried out for 1 h at 37°C and were terminated 
on ice by the addition of an excess of unlabeled NAD. After tri- 
chloroacetic acid precipitation, samples were subjected to SDS- 
PAGE and dried gels were subjected to autoradiography with an 
X-omat 2 Kodak film. 
2.5. Measurement of phosphoinositide breakdown 
Confluent cultures were arrested and labeled to equilibrium 
with myo-[3H]inositol (4 &i/ml) for 24 h in serum-free MEM. 
PT was added directly to the medium 12 h before addition of 
GFs. Cells were extensively washed with a buffer containing 
150 mM NaCl, 5.4 mM KCI, 1.8 mM CaQ, 8 mM MgS04, 
25 mM glucose, 20 mM Tris-HCI (pH 7.4), then incubated with 
10 mM LiCl for 5 min. Thereafter the cultures were stimulated 
with GFs at the indicated concentrations: serum (lo%, v/v), 
thrombin (1 IU/ml) in 300 ~1 of fresh Li+ containing solution 
for 60 min. The reaction was stopped by extracting the cells with 
HClO+ Separation of [‘Hlinositol phosphates was carried out 
as described by Bone [ 141. 
2.6. Reagents 
Human a-thrombin was from Sigma. PT was a gift from the 
Merieux Institute, France. [c~-“PINAD (28 Ci/mmol) was ob- 
tained from New England Nuclear and myo-[‘Hlinositol 
(14.3 Ci/mmol) from Amersham. 
3. RESULTS 
3.1. Pertussis toxin and cell growth 
Table 1 summarizes the results concerning the 
phenotypic characteristics of the 3T3 control and 
transformed cells. 3T3 cells, after integration in 
their genome of one of the oncogenes (Ha-ras, c-m 
or SV40), acquired a transformed phenotype as 
judged from their ability to clone in agar and to 
form tumors in nude mice. After transfection or in- 
fection, morphological transformation was judged 
Table 1 
Growth characteristics and tumorinenicitv of 3T3 cells and derivatives 
Control cells 
(3T3 cells) 
Transformed cells 
3T3/Ha-ras 3T3/src 3T3/SV40 
Morphological transformation - + + + 
Loss of contact inhibition of cell division _ + + + 
Growth in semi-solid medium (% of clones) 0 12 5 7 
Growth in semi-solid medium of cells pretreated with PT (vo of clones) 0 12 5 2 
Doubling time (h) 22 12 16 17 
Tumorigenicity in nude mice - + + + 
The numbers of clones in agar were, respectively, for 3T3/Ha-ras, 3T3/src and 3T3/SV40, 90 + 7, 37 + 4 and 52 k 5. Data are means 
+ SE of quadruplicate determinations. When different cell lines were pretreated overnight with PT (100 ng/ml), the numbers of clones 
were 92 + 5 for 3T3/Ha-ras, 38 + 3 for 3T3/src and 15 + 2 for 3T3/SV40 cells. These experiments were repeated several times 
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Fig. 1. Effect of PT on the growth of control and transformed 
3T3-cell lines. Normal 3T3 fibroblasts (A), 3T3/SV40 (B), 
3T3/Ha-ras (C) or 3T3/src (D) were seeded respectively at 
6 x 103, 9 x lo”, 3.5 x 10’ and 10 x 10’ cells per dish. Pertussis 
toxin (10 ng/ml) was added with fresh medium at day 0, 2 and 
4 and the number of cells was determined as indicated in section 
2. Treated (u); untreated (M). 
by the appearance of spherical or spindle shape 
cells and the refractive appearance of the trans- 
formed cells. The tumorigenicity of the trans- 
formed clones was evaluated by the appearance of 
100% of tumors, without any latency, after injec- 
tion of 2 x lo6 cells per animal (not shown). PT 
does not affect the ability of 3T3/Ha-rus or 
3T3/src to form clones in soft agar. In contrast, 
overnight treatment of 3T3/SV40 with 100 ng/ml 
of PT significantly decreases the number and size 
of the clones. We have measured the growth rate of 
control and transformed cells in the presence of 
10 ng/ml of PT (fig.1). 3T3 fibroblasts are very 
sensitive to PT treatment. After 7 days of treat- 
ment, the number of cells is decreased by 80%. PT 
slows down normal 3T3 cell growth with an I& of 
about 1 ng/ml. Interestingly, 3T3 cells trans- 
formed with SV40 virus, like normal cells, retain 
full sensitivity to PT treatment. After 7 days treat- 
ment the number of 3T3/SV40 cells was decreased 
by 75%. Cells transformed with Ha-ras or C-SK do 
not show any sensitivity to PT even at concentra- 
tions up to 100 ng/ml. These data imply that 
transformation with SV40 does not orientate the 
mitogenic signals toward steps which are complete- 
ly insensitive to PT as it does following transforma- 
tion with Ha-ras or src oncogenes. 
3.2. Phospholipase C activity in 3T3 cells 
transformed with different oncogenes 
As receptor activation of phospholipase C is 
mediated by a GTP-binding protein sensitive to PT 
in 3T3 cells [12], and as it has been demonstrated 
that the activation of phospholipase C is a 
necessary step mediating the mitogenic effect of 
serum and thrombin [16], we measured accumula- 
tion of inositol phosphates (IP) in the different cell 
lines. 
Accumulation of IP was measured in the 
presence of Li+ after stimulation by serum (10%) 
or thrombin (1 IU/ml) with or without pretreat- 
ment with PT (100 ng/ml). Serum and thrombin 
stimulate IP formation in control cells in the 
absence of PT treatment (table 2). This stimulation 
is significantly reduced after toxin treatment. 
Table 2 
Stimulation of IP formation by serum (10%) or thrombin 
(1 IU/ml) in the presence or absence of PT 
% stimulation 
No pretreatment PT pretreatment 
3T3/control serum 83 43 (47) 
thrombin 61 24 (61) 
3T3/Ha-ras serum 13 12 (7) 
thrombin 25 26 (0) 
3T3/src serum 13 13 (0) 
thrombin 35 32 (9) 
3T3/SV40 serum 29 10 (64) 
thrombin 33 20 (40) 
Basal activities of IP accumulation for 3T3 control, 3T3/Ha- 
ras, 3T3/src and 3T3/SV40 cells were respectively 260 f 20, 
237 f 15,293 f 23 and 250 + 20 fmol/106 cells (data are means 
f SE of triplicate determinations). Data in parentheses are the 
percentages of inhibition elicited by pretreatment of the cells 
with 100 ng/ml of PT. Data represent a typical experiment. 
Values for @IO of stimulation are the average of triplicates. Ex- 
periments were repeated five times 
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In Ha-ras and src-transformed cells, however, 
the basal phospholipase C activity is not modified 
and the stimulated production of IP never exceed- 
ed 35% over basal, either after serum or thrombin 
treatment. PT equally failed to modify residual 
production of IP in these cells. Similar data were 
obtained with c-Ki-ras and N-ras transformed 3T3 
cells (not shown). A kinetic study of IP accumula- 
tion or the use of different concentrations of serum 
or thrombin gave identical results (not shown). In 
3T3/SV40 cells, we observed the same desensitiza- 
tion to serum and thrombin as in the other trans- 
formed cell lines but PT was still able to block par- 
tially IP formation. 
3.3. Labeling with a’P]NAD of PT substrates 
PT can ADP-ribosylate several related GTP- 
binding proteins in 3T3 cells [lo]. 
We compared PT catalyzed ADP-ribosylation 
profiles of homogenates from the different clones. 
PT-dependent labeling of a 40 kDa band was 
visualized in 3T3 control cells (fig.2). The same 
pattern of ADP-ribosylation was obtained for the 
transformed clones except in the case of the 
3T3/Ha-ras cells which displayed a reduced incor- 
Fig.2. Pertussis toxin-dependent ADP-ribosylation of 40 kDa 
substrates (arrow), in homogenates prepared from (a) Swiss 
3T3, (b) 3T3/Ha-ras, (c) 3T3/SV40, (d) 3T3/src cells. Cells were 
pretreated (+) or not (- ) overnight with 100 ng/ml of toxin. 
ADP-ribosylation was performed and 100 pg proteins were sub- 
jected to SDS-PAGE (12.5%) and autoradiographed as describ- 
ed in section 2. 
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poration of [32P]ADP-ribose. The reduced amount 
of incorporation of [32P]ADP-ribose into the 
40 kDa band does not seem to be specific of either 
the Ha-ras gene or ras gene family since we ob- 
tained different results with Ki-ras or N-ras trans- 
formed cells and EJ/T24/Ha-ras cells (not shown). 
Preincubation of the cells with 100 ng/ml of PT 
abolished the in vitro labeling, showing that the 
toxin can still reach its substrates in every clone 
tested. 
4. DISCUSSION 
In this paper, we have studied the ability of PT 
to control growth rate and IP production in 3T3 
fibroblasts transformed with different oncogenes. 
PT exerts absolutely no effect on the growth rate of 
ras and src 3T3 transformed cells but dramatically 
decreases the growth rate of SV40 virus trans- 
formed 3T3 cells and of 3T3 control cells. The im- 
portant point is that transformation with SV40 
does not confer a resistant phenotype to PT. SV40 
virus products (T and t antigens) act at the cellular 
DNA level or in the cytoplasm rather than on a 
membrane phenomenon [151. src and ras products 
are anchored in the cytoplasmic membrane [1,221. 
PT discriminates between ‘different transforming’ 
oncogenes. This difference between the oncogenes 
is considerably reinforced by the fact that in vitro 
clonogenicity of 3T3/SV40 cells is diminished by 
PT. This means that PT blocks essential informa- 
tion for the complete expression of the 3T3/SV40 
cell transformed phenotype. PT is known to con- 
trol cell growth [9,10] as well as to block the in- 
ositol lipid pathway in 3T3 normal fibroblasts [ 161. 
Therefore, we measured the ability of PT to 
decrease serum- and thrombin-induced release of 
IP in the presence of Li+ in transformed cells. As 
reported by others [17,18] accumulation of diacyl- 
glycerol is a common phenomenon in a large 
number of mammalian transformed cells, sug- 
gesting increased PIP2 turnover [19]. It has been 
previously shown that a direct relationship exists 
between ras proteins and phospholipase C (5,201. 
Indeed, an increased production of IP has been 
reported in response to respectively bombesin or 
PDGF polypeptides, using a hormone-regulated 
construction of cellular ras genes, causing overex- 
pression of either N-ras protein [5] or Ha-ras pro- 
tein [20]. If we assume that mutated forms of c-Ha- 
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T(IS are permanently activated [18] and participate 
directly in the PI cycle, increased IP formation 
should be detectable in cells transformed specifical- 
ly with this oncogene. Our data show that the basal 
rate of IP formation was unchanged in all the 
transformed cells tested and that complete depres- 
sion of the serum- and thrombin-induced stimula- 
tion of IP accumulation occurs. These data are not 
in favor of a direct interaction between ras proteins 
and phospholipase C. Similar observations were 
made in Ha-ras 3T3 transformed cells [8,21] or Ha- 
rus CCL39 transformed cells [6]. The residual 
stimulation of IP formation was no longer sensitive 
to PT in the presence of SK or ras transforming 
proteins, but was comparable to that of control 
cells when large T and small t SV40 proteins were 
produced. Lack of PT activity cannot be explained 
by the disappearance of PT substrates or PT- 
binding units in the transformed cells. Indeed, in 
vivo ADP-ribosylation assay (fig.2) and ALFl 
stimulation of PIP2 breakdown (not shown) were 
still positive in every cell line. 
A decreased number of cell receptors coupled to 
PIP2 breakdown cannot be ruled out even though 
such a phenomenon has not yet been reported. It is 
more likely that mutated ras and STC proteins turn 
off the phosphoinositide mitogenic pathway by an 
unknown mechanism which favors the tyrosine 
kinase stimulation of DNA synthesis. Indeed, it 
has been demonstrated that ras proteins are 
necessary for SK transformed phenotype expres- 
sion [22,23]. Thus, it is not surprising that src and 
mutated rus confer the same resistant phenotype to 
PT. Our data suggest that, when oncogenes uch as 
src or rus are present, transduction pathways sen- 
sitive to PT, such as GF-induced IP formation or 
GF-induced decrease of cellular CAMP, are not 
necessary for mitogenicity. A different situation is 
generated by SV40 transformation, which does not 
impair the mitogenic signals transduced through 
PT substrates. It would be of considerable impor- 
tance to know how src and t-us proteins desensitize 
PT-sensitive mitogenic pathways. 
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